Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cytek Biosciences, Inc.

Cytek Biosciences, Inc. (CTKB) Stock Overview

Explore Cytek Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CTKB●NASDAQ
HealthcareMedical - Devices
$5.76
$0.02(0.35%)
U.S. Market opens in 3h 18m

Cytek Biosciences, Inc. (CTKB)

Meyka AI Score

Z

Key Financials

Market Cap743.9M
P/E Ratio-9.14
EPS (TTM)$-0.19
ROE-0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$5.37
3 Months$6.38
1 Year Target$5.23

CTKB Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cytek Biosciences, Inc. (NASDAQ: CTKB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Cytek Biosciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CTKB on the NASDAQ shows an RSI of 73.97, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $5.23 for the NASDAQ listing.

Key metrics behind Cytek Biosciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -9.14 and a market capitalization of 743.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CTKB on the NASDAQ.

Price Performance (NASDAQ: CTKB)

1-Day Change
0.35%
5-Day Change
2.13%
1-Month Change
23.08%
3-Month Change
32.72%
6-Month Change
33.33%
Year-to-Date (YTD) Change
14.06%
1-Year Change
70.41%
3-Year Change
4.35%
5-Year Change
-72.52%
All-Time (Max) Change
-69.30%

Contact Information

https://cytekbio.com
877 922 9835
47215 Lakeview Boulevard, Fremont, CA, 94538-6407

Company Facts

6,820 Employees
IPO DateJul 23, 2021
CountryUS
Actively Trading

Frequently Asked Questions